Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax-embedded tissues and imprint-cytology specimens

Clinical and Experimental Dermatology

Volumn 37, Issue 8, 2012, Pages 838-843

  Abasolo A ^a   Vargas, M T ^a   Rios Martin J J ^a   Trigo, I ^a   Arjona, A ^a   Gonzalez Campora R ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CENTROMERE OF CHROMOSOME 6; CYCLIN D1; MEMBRANE PROTEIN; MYELOBLASTOSIS VIRAL ONCOGENE HOMOLOGUE PROTEIN; PARAFFIN; RAS RESPONSIVE ELEMENT BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; FALSE POSITIVE RESULT; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE; MELANOCYTE; MELANOCYTIC NEVUS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CYTOLOGICAL TECHNIQUES; DNA PROBES; DNA-BINDING PROTEINS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEVUS, PIGMENTED; PARAFFIN EMBEDDING; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84870057404     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2012.04416.x     Document Type: Article

References (16)

1. Rigel DS, Carucci JA,. Malignant melanoma: prevention, early detection, and treatment in the 21st century. CA Cancer J Clin 2000; 50: 215-36; quiz 37-40.
2. Beddingfield FC III The melanoma epidemic: res ipsa loquitur. Oncologist 2003; 8: 459-65.
3. Carlson JA, Ross JS, Slominski AJ,. New techniques in dermatopathology that help to diagnose and prognosticate melanoma. Clin Dermatol 2009; 27: 75-102.
4. Farmer ER, Gonin R, Hanna MP,. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 1996; 27: 528-31.
5. Veenhuizen KC, De Wit PE, Mooi WJ, et al. Quality assessment by expert opinion in melanoma pathology: experience of the pathology panel of the Dutch Melanoma Working Party. J Pathol 1997; 182: 266-72.
6. McGinnis KS, Lessing SR, Elder DE, et al. Pathology review of cases presenting to a multidisciplinary pigmented lesion clinic. Arch Dermatol 2002; 138: 617-21.
7. Lodha S, Saggar S, Celebi JT, et al. Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting. J Cutan Pathol 2008; 35: 349-52.
8. Gerami P, Jewell SS, Morrison LE, et al. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol 2009; 33: 1146-56.
9. Newman MD, Lertsburapa T, Mirzabeigi M, et al. Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma. Mod Pathol 2009; 22: 989-95.
10. Newman MD, Mirzabeigi M, Gerami P,. Chromosomal copy number changes supporting the classification of lentiginous junctional melanoma of the elderly as a subtype of melanoma. Mod Pathol 2009; 22: 1258-62.
11. Morey AL, Murali R, McCarthy SW, et al. Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation. Pathology 2009; 41: 383-7.
12. Gerami P, Wass A, Mafee M, et al. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi. Am J Surg Pathol 2009; 33: 1783-8.
13. Pouryazdanparast P, Newman M, Mafe M, et al. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybrodation. Am J Surg Pathol 2009; 33: 1396-400.
14. Dalton M, Gerami P, Kolatis N, et al. Use fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastasic melanoma. Am J Surg Pathol 2010; 34: 231-7.
15. Gaiser T, Kutzner H, Palmedo G, et al. Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up. Mod Pathol 2010; 23: 413-19.
16. Gerami P, Mafee M, Lurtsbarapa T, et al. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep 6 and 11q13 probes in melanoma subtypes. Arch Dermatol 2010; 146: 273-8.